Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Publication Details

Chronic heart failure

Hopper I, Easton K

(2017), Aust Prescr, 40(4), 128-36

DOI: 10.18773/austprescr.2017.044

Effect of renal denervation on kidney function in patients with chronic kidney disease

Hering D, Marusic P, Duval J, Sata Y, Head GA, Denton KM, Burrows S, Walton AS, Esler MD, Schlaich MP

(2017), Int J Cardiol, 232, 93-7

DOI: 10.1016/j.ijcard.2017.01.047

Microvascular leakage in acute myocardial infarction: characterization by histology, biochemistry, and magnetic resonance imaging

Gao XM, Wu QZ, Kiriazis H, Su Y, Han LP, Pearson JT, Taylor AJ, Du XJ

(2017), Am J Physiol Heart Circ Physiol, 312(5), H1068-75

DOI: 10.1152/ajpheart.00073.2017

Inhibition of the renin-angiotensin system post myocardial infarction prevents inflammation-associated acute cardiac rupture

Gao XM, Tsai A, Al-Sharea A, Su Y, Moore S, Han LP, Kiriazis H, Dart AM, Murphy AJ, Du XJ

(2017), Cardiovasc Drugs Ther, 31(2), 145-56

DOI: 10.1007/s10557-017-6717-2

Rivaroxaban in the treatment of PICC-associated upper extremity venous thrombosis

Fan F, Zou Y, Zhang S, Zhang Y, Lan B, Song Q, Pei M, He L, Wu H, Du Y, Dart AM

(2017), Clin Ther, 39(9), 1882-8

DOI: 10.1016/j.clinthera.2017.07.041

Hypertrophic cardiomyopathy in the adolescent

Ellims AH

(2017), Aust Fam Physician, 46(8), 553-557

Soluble vascular endothelial growth factor receptor-1 is reduced in patients with resistant hypertension after renal denervation

Eikelis N, Hering D, Marusic P, Walton AS, Lambert EA, Sata Y, Krum H, Lambert GW, Esler MD, Schlaich MP

(2017), J Hum Hypertens, 31(4), 248-52

DOI: 10.1038/jhh.2016.64

Predictors of incident heart failure in patients after an acute coronary syndrome: the LIPID heart failure risk-prediction model

Driscoll A, Barnes EH, Blankenberg S, Colquhoun DM, Hunt D, Nestel PJ, Stewart RA, West MJ, White HD, Simes J, Tonkin A

(2017), Int J Cardiol, 248, 361-8

DOI: 10.1016/j.ijcard.2017.06.098

Should pulse pressure influence prescribing?

Dart AM

(2017), Aust Prescr, 40(1), 26-9

DOI: 10.18773/austprescr.2017.006

Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites

Braig D, Nero TL, Koch HG, Kaiser B, Wang X, Thiele JR, Morton CJ, Zeller J, Kiefer J, Potempa LA, Mellett NA, Miles LA, Du XJ, Meikle PJ, Huber-Lang M, Stark GB, Parker MW, Peter K, Eisenhardt SU

(2017), Nat Commun, 8, 14188

DOI: 10.1038/ncomms14188

Novel thrombolytic drug based on thrombin cleavable microplasminogen coupled to a single-chain antibody specific for activated GPIIb/IIIa

Bonnard T, Tennant Z, Niego B, Kanojia R, Alt K, Jagdale S, Law LS, Rigby S, Medcalf RL, Peter K, Hagemeyer CE

(2017), J Am Heart Assoc, 6(2), e004535

DOI: 10.1161/JAHA.116.004535

Novel antithrombotic drugs on the horizon: the ultimate promise to prevent clotting while avoiding bleeding

McFadyen JD, Peter K

(2017), Circ Res, 121(10), 1133-5

DOI: 10.1161/CIRCRESAHA.117.312012

Molecular sensors of blood flow in endothelial cells

Baratchi S, Khoshmanesh K, Woodman OL, Potocnik S, Peter K, McIntyre P

(2017), Trends Mol Med, 23(9), 850-68

DOI: 10.1016/j.molmed.2017.07.007

Development of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statistics

Backholer K, Hirakawa Y, Tonkin A, Giles G, Magliano DJ, Colagiuri S, Harris M, Mitchell P, Nelson M, Shaw JE, Simmons D, Simons L, Taylor A, Harding J, Gopinath B, Woodward M

(2017), BMC Cardiovasc Disord, 17, 17

DOI: 10.1186/s12872-016-0462-5

Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans

Loh RKC, Formosa MF, Eikelis N, Bertovic DA, Anderson MJ, Barwood SA, Nanayakkara S, Cohen ND, La Gerche A, Reutens AT, Yap KS, Barber TW, Lambert GW, Cherk MH, Duffy SJ, Kingwell BA, Carey AL

(2017), Diabetologia, 61(1), 220-30

DOI: 10.1007/s00125-017-4479-9

Therapeutic Guidelines: Cardiovascular, Therapeutic Guidelines Limited, Melbourne

Atherton J, Campbell T, Connell C, Curnow J, Dooley S, Gibbs H, Hazell W, Hopper I, Kritharides L, Liew D, Molga A, Nelson M, Roberts-Thomson K, Scherer D, Strathmore N, Thomas J

(2017), 7,

Assessment of the accuracy of common clinical thresholds for cardiac morphology and function by transthoracic echocardiography

Alexis JA, Costello B, Iles LM, Ellims AH, Hare JL, Taylor AJ

(2017), J Echocardiogr, 15(1), 27-36

DOI: 10.1007/s12574-016-0322-4

A unique recombinant fluoroprobe targeting activated platelets allows in vivo detection of arterial thrombosis and pulmonary embolism using a novel three-dimensional fluorescence emission computed tomography (FLECT) technology

Lim B, Yao Y, Huang AL, Yap ML, Flierl U, Palasubramaniam J, Zaldivia MTK, Wang X, Peter K

(2017), Theranostics, 7(5), 1047-61

DOI: 10.7150/thno.18099

Nanoliposomes for safe and efficient therapeutic mRNA delivery: a step toward nanotheranostics in inflammatory and cardiovascular diseases as well as cancer

Abraham MK, Peter K, Michel T, Wendel HP, Krajewski S, Wang X

(2017), Nanotheranostics, 1(2), 154-65

DOI: 10.7150/ntno.19449

The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia

Fox LC, Cummins KD, Costello B, Yeung D, Cleary R, Forsyth C, Tatarczuch M, Burbury K, Motorna O, Shortt J, Fleming S, McQuillan A, Schwarer A, Harrup R, Holmes A, Ratnasingam S, Chan KL, Hsu WH, Ashraf A, Putt F, Grigg A

(2017), Blood Adv, 1(13), 802-11

DOI: 10.1182/bloodadvances.2016003889